Cocrystal Pharma, Inc.
COCP
$1.49
-$0.06-3.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.92M | 9.86M | 13.02M | 18.14M | 21.84M |
| Total Receivables | 1.45M | 1.22M | 652.00K | 1.08M | 1.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 385.00K | 430.00K | 509.00K | 365.00K | 1.57M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 75.00K | 75.00K | 75.00K | 75.00K | 75.00K |
| Total Current Assets | 8.83M | 11.58M | 14.26M | 19.66M | 24.49M |
|
|
|||||
| Total Current Assets | 8.83M | 11.58M | 14.26M | 19.66M | 24.49M |
| Net Property, Plant & Equipment | 1.75M | 1.85M | 1.95M | 1.88M | 2.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 86.00K | 29.00K | 29.00K | 29.00K | 46.00K |
| Total Assets | 10.66M | 13.46M | 16.23M | 21.57M | 26.55M |
|
|
|||||
| Total Accounts Payable | 808.00K | 1.54M | 859.00K | 1.74M | 1.23M |
| Total Accrued Expenses | 814.00K | 585.00K | 796.00K | 660.00K | 905.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 309.00K | 301.00K | 293.00K | 251.00K | 240.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.93M | 2.43M | 1.95M | 2.65M | 2.38M |
|
|
|||||
| Total Current Liabilities | 1.93M | 2.43M | 1.95M | 2.65M | 2.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.42M | 1.51M | 1.58M | 1.53M | 1.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.36M | 3.93M | 3.53M | 4.18M | 3.96M |
|
|
|||||
| Common Stock & APIC | 343.02M | 342.94M | 342.86M | 342.60M | 342.46M |
| Retained Earnings | -335.72M | -333.42M | -330.15M | -325.21M | -319.87M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.30M | 9.52M | 12.70M | 17.39M | 22.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.30M | 9.52M | 12.70M | 17.39M | 22.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.30M | 9.52M | 12.70M | 17.39M | 22.59M |
|
|
|||||